Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)

NEXT STORY
Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update
PREV STORY
ALBERTA BOEHRINGER INGELHEIM COLLABORATION FUND ANNOUNCES NEW RESEARCH FOR PATIENTS LIVING WITH RESPIRATORY DISEASE
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tyme Schedules Conference Call to Discuss SM-88 Preliminary Phase II Pancreatic Cancer Data on Friday, January 18th

NEW YORK, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), a ...

author_avatar
NASDAQ Market News

AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires

Birgitte Volck, M.D., Ph.D., is appointed President of Research and Development and will oversee ...

author_avatar
NASDAQ Market News

Targovax ASA: New member of the board of directors

Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company ...

author_avatar
NASDAQ Market News